Read + Share
Amedeo Smart
Independent Medical Education
Yuan Y, Lee JS, Yost SE, Frankel PH, et al. Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer. Eur J Cancer 2021;154:11-20.PMID: 34217908
Email
LinkedIn
Facebook
Twitter
Privacy Policy